REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 182 filers reported holding REGENXBIO INC in Q3 2022. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,347 | -25.3% | 81,807 | -9.4% | 0.00% | 0.0% |
Q2 2023 | $1,804 | +42.9% | 90,275 | +35.2% | 0.00% | 0.0% |
Q1 2023 | $1,262 | -42.4% | 66,748 | -30.9% | 0.00% | 0.0% |
Q4 2022 | $2,192 | -99.9% | 96,608 | +13.5% | 0.00% | -50.0% |
Q3 2022 | $2,250,000 | +509.8% | 85,145 | +470.3% | 0.00% | – |
Q2 2022 | $369,000 | -76.6% | 14,930 | -68.6% | 0.00% | -100.0% |
Q1 2022 | $1,577,000 | -64.2% | 47,546 | -64.7% | 0.00% | 0.0% |
Q4 2021 | $4,406,000 | +55.4% | 134,746 | +99.2% | 0.00% | 0.0% |
Q3 2021 | $2,835,000 | +108.1% | 67,629 | +93.0% | 0.00% | 0.0% |
Q2 2021 | $1,362,000 | -43.4% | 35,038 | -50.3% | 0.00% | 0.0% |
Q1 2021 | $2,405,000 | +30.7% | 70,498 | +73.8% | 0.00% | 0.0% |
Q4 2020 | $1,840,000 | -6.9% | 40,554 | -43.5% | 0.00% | 0.0% |
Q3 2020 | $1,976,000 | -39.7% | 71,769 | -19.3% | 0.00% | -66.7% |
Q2 2020 | $3,275,000 | +12.2% | 88,963 | -1.3% | 0.00% | +50.0% |
Q1 2020 | $2,918,000 | -61.8% | 90,125 | -51.7% | 0.00% | -50.0% |
Q4 2019 | $7,646,000 | +252.0% | 186,668 | +206.1% | 0.00% | +300.0% |
Q3 2019 | $2,172,000 | -38.1% | 60,989 | -10.7% | 0.00% | -50.0% |
Q2 2019 | $3,508,000 | -26.3% | 68,277 | -17.7% | 0.00% | -33.3% |
Q1 2019 | $4,757,000 | +179.7% | 82,979 | +104.5% | 0.00% | +200.0% |
Q4 2018 | $1,701,000 | -33.2% | 40,573 | +20.3% | 0.00% | -50.0% |
Q3 2018 | $2,547,000 | +98.7% | 33,738 | +88.7% | 0.00% | +100.0% |
Q2 2018 | $1,282,000 | +108.8% | 17,878 | -12.9% | 0.00% | – |
Q1 2018 | $614,000 | +17.9% | 20,515 | +30.9% | 0.00% | – |
Q4 2017 | $521,000 | +28.0% | 15,678 | +26.8% | 0.00% | – |
Q3 2017 | $407,000 | +107.7% | 12,361 | +24.6% | 0.00% | – |
Q2 2017 | $196,000 | +127.9% | 9,921 | +120.9% | 0.00% | – |
Q1 2017 | $86,000 | -16.5% | 4,492 | -19.1% | 0.00% | – |
Q4 2016 | $103,000 | +5050.0% | 5,555 | +4274.0% | 0.00% | – |
Q3 2016 | $2,000 | 0.0% | 127 | +17.6% | 0.00% | – |
Q4 2015 | $2,000 | – | 108 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |